U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662330) titled 'Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia' on April 07.
Brief Summary: Evaluate the effect of spermidine supplementation on lipid profile changes in individuals with overweight or obesity accompanied by hyperlipidemia. Analyze the impact of spermidine on metabolic parameters and assess the safety of spermidine supplementation, including liver and kidney function, gastrointestinal reactions, and other adverse effects.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Obesity & Overweight
Hyperlipidemia
In...